(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-41.94% US12542Q70 0.168
Live Chart Being Loaded With Signals
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics...
Stats | |
---|---|
Šios dienos apimtis | 18.26M |
Vidutinė apimtis | 1.27M |
Rinkos kapitalizacija | 1.14M |
EPS | US12542Q700 ( 2024-03-05 ) |
Kita pelno data | ( US12542Q70-0.930 ) 2024-05-14 |
Last Dividend | US12542Q700 ( N/A ) |
Next Dividend | US12542Q700 ( N/A ) |
P/E | -0.0100 |
ATR14 | US12542Q700.00100 (0.59%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Mccormick Michael Kendrick | Buy | 20 836 | Nonstatutory Stock Option (right to buy) |
2024-01-02 | Mcdonald David | Buy | 11 365 | Nonstatutory Stock Option (right to buy) |
2024-01-02 | Feldshon Archelle Georgiou | Buy | 11 365 | Nonstatutory Stock Option (right to buy) |
2023-11-01 | Mcdonald David | Buy | 0 | |
2023-11-01 | Feldshon Archelle Georgiou | Buy | 0 |
INSIDER POWER |
---|
97.91 |
Last 90 transactions |
Buy: 3 285 386 | Sell: 12 287 |
Tūris Koreliacija
Nuwellis, Inc. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Nuwellis, Inc. Koreliacija - Valiuta/Žaliavos
Nuwellis, Inc. Finansinės ataskaitos
Annual | 2023 |
Pajamos: | US12542Q708.86M |
Bruto pelnas: | US12542Q704.98M (56.22 %) |
EPS: | US12542Q70-10.29 |
FY | 2023 |
Pajamos: | US12542Q708.86M |
Bruto pelnas: | US12542Q704.98M (56.22 %) |
EPS: | US12542Q70-10.29 |
FY | 2022 |
Pajamos: | US12542Q708.54M |
Bruto pelnas: | US12542Q704.76M (55.66 %) |
EPS: | US12542Q70-83.48 |
FY | 2021 |
Pajamos: | US12542Q707.92M |
Bruto pelnas: | US12542Q704.49M (56.70 %) |
EPS: | US12542Q70-285.73 |
Financial Reports:
No articles found.
Nuwellis, Inc.
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.